Displaying 1 - 1 of 1
| Active Ingredient | FLUTICASONE | VILANTEROL |
| Therapeutic Class | RESPIRATORY AGENTS MISCELLANEOUS |
| Indications | Long-term maintenance of airflow obstruction in p atients with chronic obstructive pulmonary disease (COPD). |
| Caution |
Close monitoring for glaucoma and cataracts is warranted. Do not use in combination with an additional LABA because of risk of overdose. Naso-pharyngitis, upper respiratory tract infection, hea More ... |
| Dose Range | One inhalation once daily at the same time each day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |